• The power of local knowledge
    on a global scale.

    No matter where your clinical development takes you, we're already there. Where are you today?

  • We are dedicated to
    the future of clinical development
    and to every life it saves.

    Learn more about why we do what we do, and what we can do for you. Click to read our story.

  • There's just no denying
    good chemistry

    Explore the PRA HEALTH SCIENCES interactive experience to find out what makes us tick.

Social Media

See the latest interactions from our social media


The ASQ World Conference on Quality and Improvement starts on Monday at Gaylord Opryland Resort & Convention...

View Post

Featured News

Read the latest updates from our PR department

PRA is Named International Clinical Company of the Year

27 April 2015, Raleigh, N.C. – PRA Health Sciences (PRA) is pleased to announce that it was named Clinical Company of the Year at the International Clinical Researcher of the Year award...

PRA Health Sciences to Report First Quarter 2015 Results

17 April 2015, Raleigh, N.C. – PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its first quarter 2015 results after the market closes on Wednesday, May 6, 2015. The Company will also...

PRA Health Sciences to Add New Jobs in Swansea

17 April 2015, Raleigh, N.C. – PRA Health Sciences (PRA), a leading global clinical research organization, is expanding its business in Swansea with the creation of 87 new jobs. The...

Read More >

Media Resources

Explore the latest resources uploaded to our media library

Sign Up for PRA's Industry Watch

Brought to you by PRA Health Sciences. A Bi-Weekly Industry Watch Newsletter

CASE STUDY: PRA Feasibility Leads To Unique Enrollment Strategy

PRA recently performed a feasibility study to identify investigators who see patients with a rare neuromuscular autoimmune disease and who have the capability to perform a Phase II clinical trial.


PRA Health Sciences provides our clients with innovative solutions for CNS (neurology, psychiatry, and pain) drug development. Our work spans from early phase development to NDA and MAA submissions...

CASE STUDY: PRA Teamwork Demonstrates Vision

A large pharmaceutical client selected PRA to conduct 2 Phase III epilepsy studies in India, Eastern and Western Europe, and Australia. PRA’s project teams surpassed recruitment goals and achieved timely site activations despite administrative delays and tough competition for volunteers.


Find out what's happening next on PRA's event schedule

May 4 - May 6

With more than 2,500 attendees from around the world, the World Conference on Quality and Improvement is a premier international event. You have opportunities to share ideas with your domestic and global colleagues. Take this time to connect and make business relationships that will foster success for years to come. Speakers: Dana Baird (Process Analyst), […]

May 5 - May 7

The 11th Annual Biomarkers & Diagnostics World Congress 2015 will be held May 5-7, 2015 in Philadelphia, Pennsylvania. The event brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers. The World Congress […]

May 11 - May 12

NextLevel Pharma’s “Oncology Clinical Leaders Forum” will bring to together experts from all stakeholder groups (i.e. researchers, regulators, patient groups, health technology assessors) for an important and timely debate and to share knowledge on how to overcome the massive scientific, operational, financial and economic obstacles to developing more effective, safe, affordable and patient-relevant oncology therapies […]

Read More >